The circulating levels of liver enzymes (aspartate transaminase [AST], and alanine transaminases [ALT]), other nonenzymatic proteins (albumin) and metabolites of heme (bilirubin) are routinely used to diagnose and monitor liver diseases, including NAFLD/NASH (138). The gene discussed is GPT; the disease is liver disorder.